113 related articles for article (PubMed ID: 1395561)
1. The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice.
Gruner S; Zwirner A; Strunk D; Sönnichsen N
Contact Dermatitis; 1992 Apr; 26(4):241-7. PubMed ID: 1395561
[TBL] [Abstract][Full Text] [Related]
2. [Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Gruner S; Strunk D; Diezel W
Dermatol Monatsschr; 1987; 173(8):436-40. PubMed ID: 2959574
[No Abstract] [Full Text] [Related]
3. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
Czernielewski J; Juhlin L; Shroot S; Brun P
Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous reactivity of murine epidermal Langerhans cells after application of FITC: a histochemical evaluation.
Doi S; Kobayashi M; Sugiura Y; Sakamoto T; Torii S
Arch Histol Cytol; 1999 Oct; 62(4):363-73. PubMed ID: 10596947
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells.
Gruner S; Hofmann T; Meffert H; Sönnichsen N
Arch Dermatol Res; 1993; 285(5):283-6. PubMed ID: 8379688
[TBL] [Abstract][Full Text] [Related]
6. The effects of non-interval PUVA treatment on Langerhans cells and contact hypersensitivity.
Guo Z; Okamoto H; Danno K; Imamura S
J Dermatol Sci; 1992 Mar; 3(2):91-6. PubMed ID: 1599904
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
Katoh N; Hirano S; Kishimoto S; Yasuno H
Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
[TBL] [Abstract][Full Text] [Related]
9. Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
Schulze HJ; Schauder S; Mahrle G; Steigleder GK
J Am Acad Dermatol; 1987 Jul; 17(1):19-24. PubMed ID: 3611453
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem.
Diezel W; Gruner S; Diaz LA; Anhalt GJ
J Invest Dermatol; 1989 Sep; 93(3):322-6. PubMed ID: 2527909
[TBL] [Abstract][Full Text] [Related]
11. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
12. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity.
Lynch DH; Gurish MF; Daynes RA
J Immunol; 1981 May; 126(5):1892-7. PubMed ID: 6452479
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods.
Rheins LA; Young EM; Nordlund ML; Berning RB; Nordlund JJ
J Invest Dermatol; 1987 Nov; 89(5):489-94. PubMed ID: 2889782
[TBL] [Abstract][Full Text] [Related]
15. UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines.
Swinehart JM; Lowe NJ
J Am Acad Dermatol; 1991 Apr; 24(4):594-7. PubMed ID: 2033137
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice.
Singh P; Morris B; Zhao S; Blaylock BL
Int J Toxicol; 2002; 21(2):107-14. PubMed ID: 12022630
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides--role of T-suppressor cells.
Gruner S; Diezel W; Strunk D; Eckert R; Siems W; Anhalt GJ
J Invest Dermatol; 1991 Sep; 97(3):478-82. PubMed ID: 1678766
[TBL] [Abstract][Full Text] [Related]
18. The influence of photochemical treatment on immunogenicity and epidermal Langerhans cells of murine skin grafts.
Gruner S; Meffert H
Biomed Biochim Acta; 1986; 45(5):649-54. PubMed ID: 2944515
[TBL] [Abstract][Full Text] [Related]
19. The effect of 8-methoxypsoralen and long-wave ultraviolet light on Langerhans cell.
Okamoto H; Horio T
J Invest Dermatol; 1981 Oct; 77(4):345-6. PubMed ID: 6456313
[TBL] [Abstract][Full Text] [Related]
20. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
Aberer W; Romani N; Elbe A; Stingl G
J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
